Advanced search
1 file | 2.57 MB

MASK 2017 : ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

Author
Organization
Abstract
mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), the Phase 3 ARIA initiative, is based on the freely available MASK app (the Allergy Diary, Android and iOS platforms). MASK is available in 16 languages and deployed in 23 countries. The present paper provides an overview of the methods used in MASK and the key results obtained to date. These include a novel phenotypic characterization of the patients, confirmation of the impact of allergic rhinitis on work productivity and treatment patterns in real life. Most patients appear to self-medicate, are often non-adherent and do not follow guidelines. Moreover, the Allergy Diary is able to distinguish between AR medications. The potential usefulness of MASK will be further explored by POLLAR (Impact of Air Pollution on Asthma and Rhinitis), a new Horizon 2020 project using the Allergy Diary.
Keywords
App, ARIA, Asthma, Care pathways, MASK, mHealth, Rhinitis, ALLERGIC RHINITIS, HEALTH-ORGANIZATION, EUROPEAN COUNTRIES, MACVIA-ARIA, K-ANONYMITY, IMPACT, PRODUCTIVITY, TECHNOLOGY, VALIDATION, STRATEGIES

Downloads

  • 2018-MASK 2017 ARIA digitally-enabled.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 2.57 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Bousquet, J, S Arnavielhe, A Bedbrook, M Bewick, D Laune, E Mathieu-Dupas, R Murray, et al. 2018. “MASK 2017 : ARIA Digitally-enabled, Integrated, Person-centred Care for Rhinitis and Asthma Multimorbidity Using Real-world-evidence.” Clinical and Translational Allergy 8.
APA
Bousquet, J., Arnavielhe, S., Bedbrook, A., Bewick, M., Laune, D., Mathieu-Dupas, E., Murray, R., et al. (2018). MASK 2017 : ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. CLINICAL AND TRANSLATIONAL ALLERGY, 8.
Vancouver
1.
Bousquet J, Arnavielhe S, Bedbrook A, Bewick M, Laune D, Mathieu-Dupas E, et al. MASK 2017 : ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. CLINICAL AND TRANSLATIONAL ALLERGY. 2018;8.
MLA
Bousquet, J et al. “MASK 2017 : ARIA Digitally-enabled, Integrated, Person-centred Care for Rhinitis and Asthma Multimorbidity Using Real-world-evidence.” CLINICAL AND TRANSLATIONAL ALLERGY 8 (2018): n. pag. Print.
@article{8582306,
  abstract     = {mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), the Phase 3 ARIA initiative, is based on the freely available MASK app (the Allergy Diary, Android and iOS platforms). MASK is available in 16 languages and deployed in 23 countries. The present paper provides an overview of the methods used in MASK and the key results obtained to date. These include a novel phenotypic characterization of the patients, confirmation of the impact of allergic rhinitis on work productivity and treatment patterns in real life. Most patients appear to self-medicate, are often non-adherent and do not follow guidelines. Moreover, the Allergy Diary is able to distinguish between AR medications. The potential usefulness of MASK will be further explored by POLLAR (Impact of Air Pollution on Asthma and Rhinitis), a new Horizon 2020 project using the Allergy Diary.},
  articleno    = {45},
  author       = {Bousquet, J and Arnavielhe, S and Bedbrook, A and Bewick, M and Laune, D and Mathieu-Dupas, E and Murray, R and Onorato, GL and P{\'e}pin, JL and Picard, R and Portejoie, F and Costa, E and Fonseca, J and Louren\c{c}o, O and Morais-Almeida, M and Todo-Bom, A and Cruz, AA and da Silva, J and Serpa, FS and Illario, M and Menditto, E and Cecchi, L and Monti, R and Napoli, L and Ventura, MT and De Feo, G and Larenas-Linnemann, D and Fuentes Perez, M and Huerta Villabolos, YR and Rivero-Yeverino, D and Rodriguez-Zagal, E and Amat, F and Annesi-Maesano, I and Bosse, I and Demoly, P and Devillier, P and Fontaine, JF and Just, J and Kuna, TP and Samolinski, B and Valiulis, A and Emuzyte, R and Kvedariene, V and Ryan, D and Sheikh, A and Schmidt-Grendelmeier, P and Klimek, L and Pfaar, O and Bergmann, KC and M{\"o}sges, R and Zuberbier, T and Roller-Wirnsberger, RE and Tomazic, P and Fokkens, WJ and Chavannes, NH and Reitsma, S and Anto, JM and Cardona, V and Dedeu, T and Mullol, J and Haahtela, T and Salim{\"a}ki, J and Toppila-Salmi, S and Valovirta, E and Gemicio\u{g}lu, B and Yorgancioglu, A and Papadopoulos, N and Prokopakis, EP and Bosnic-Anticevich, S and O{\textquoteright}Hehir, R and Ivancevich, JC and Neffen, H and Zernotti, E and Kull, I and Melen, E and Wickman, M and Bachert, Claus and Hellings, P and Palkonen, S and Bindslev-Jensen, C and Eller, E and Waserman, S and Sova, M and De Vries, G and van Eerd, M and Agache, I and Casale, T and Dykewickz, M and Naclerio, RN and Okamoto, Y and Wallace, DV},
  issn         = {2045-7022},
  journal      = {CLINICAL AND TRANSLATIONAL ALLERGY},
  language     = {eng},
  pages        = {21},
  title        = {MASK 2017 : ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence},
  url          = {http://dx.doi.org/10.1186/s13601-018-0227-6},
  volume       = {8},
  year         = {2018},
}

Altmetric
View in Altmetric
Web of Science
Times cited: